{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:09:17Z","timestamp":1791425357039,"version":"4.3.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T00:00:00Z","timestamp":1173312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T00:00:00Z","timestamp":1173312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/sj.leu.2404607","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T10:20:55Z","timestamp":1173349255000},"page":"965-972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome"],"prefix":"10.1038","volume":"21","author":[{"given":"L","family":"Terrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Degan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bertorelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Noventa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"De Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,8]]},"reference":[{"key":"BF2404607_CR1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1126\/science.277.5328.955","volume":"277","author":"TM Nakamura","year":"1997","unstructured":"Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955\u2013959.","journal-title":"Science"},{"key":"BF2404607_CR2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/13495","volume":"5","author":"WC Hahn","year":"1999","unstructured":"Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999; 5: 1164\u20131170.","journal-title":"Nat Med"},{"key":"BF2404607_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.onc.1205163","volume":"21","author":"S Kyo","year":"2002","unstructured":"Kyo S, Inoue M . Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 2002; 21: 688\u2013697.","journal-title":"Oncogene"},{"key":"BF2404607_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.onc.1205075","volume":"21","author":"JH Ohyashiki","year":"2002","unstructured":"Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K . Telomeres and telomerase in hematologic neoplasia. Oncogene 2002; 21: 680\u2013687.","journal-title":"Oncogene"},{"key":"BF2404607_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00062752-200007000-00005","volume":"7","author":"TJ Kipps","year":"2000","unstructured":"Kipps TJ . Chronic lymphocytic leukemia. Curr Opin Hematol 2000; 7: 223\u2013234.","journal-title":"Curr Opin Hematol"},{"key":"BF2404607_CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS . Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219\u2013234.","journal-title":"Blood"},{"key":"BF2404607_CR7","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840\u20131847.","journal-title":"Blood"},{"key":"BF2404607_CR8","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764\u20131775.","journal-title":"N Engl J Med"},{"key":"BF2404607_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa040857","volume":"351","author":"LZ Rassenti","year":"2004","unstructured":"Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893\u2013901.","journal-title":"N Engl J Med"},{"key":"BF2404607_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","volume":"99","author":"TJ Hamblin","year":"2002","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023\u20131029.","journal-title":"Blood"},{"key":"BF2404607_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2141.1999.01620.x","volume":"106","author":"L Trentin","year":"1999","unstructured":"Trentin L, Ballon G, Ometto L, Perin A, Basso U, Chieco-Bianchi L et al. Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage. Br J Haematol 1999; 106: 662\u2013668.","journal-title":"Br J Haematol"},{"key":"BF2404607_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/blood-2003-04-1345","volume":"103","author":"RN Damle","year":"2004","unstructured":"Damle RN, Batliwalla FM, Ghiotto F, Valetto A, Albesiano E, Sison C et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood 2004; 103: 375\u2013382.","journal-title":"Blood"},{"key":"BF2404607_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.leukres.2003.11.009","volume":"28","author":"S Verstovsek","year":"2004","unstructured":"Verstovsek S, Giles FJ, O'Brien S, Faderl S, Kantarjian HM, Keating MJ et al. Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia. Leuk Res 2004; 28: 707\u2013711.","journal-title":"Leuk Res"},{"key":"BF2404607_CR14","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/annonc\/mdh389","volume":"15","author":"A Tchirkov","year":"2004","unstructured":"Tchirkov A, Chaleteix C, Magnac C, Vasconcelos Y, Davi F, Michel A et al. hTERT expression and prognosis in B-chronic lymphocytic leukemia. Ann Oncol 2004; 15: 1476\u20131480.","journal-title":"Ann Oncol"},{"key":"BF2404607_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V","volume":"91","author":"GA Ulaner","year":"2001","unstructured":"Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR . Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 2001; 91: 644\u2013649.","journal-title":"Int J Cancer"},{"key":"BF2404607_CR16","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.1038\/sj.onc.1206047","volume":"21","author":"SO Rahaman","year":"2002","unstructured":"Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ . Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 2002; 21: 8404\u20138413.","journal-title":"Oncogene"},{"key":"BF2404607_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","volume":"104","author":"L Trentin","year":"2004","unstructured":"Trentin L, Facco M, Carollo D, Tosoni A, Pizzo P, Binotto G et al. Chemokine receptor heterogeneity on neoplastic and normal B cells. Blood 2004; 104: 502\u2013508.","journal-title":"Blood"},{"key":"BF2404607_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/10428190109057952","volume":"41","author":"G Ballon","year":"2001","unstructured":"Ballon G, Trentin L, De Rossi A, Semenzato G . Telomerase activity and clinical progression in chronic lymphoproliferative disorders of B-cell lineage. Leuk Lymphoma 2001; 41: 35\u201345.","journal-title":"Leuk Lymphoma"},{"key":"BF2404607_CR19","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515\u20131525.","journal-title":"J Clin Invest"},{"key":"BF2404607_CR20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/clinchem\/39.6.1345","volume":"39","author":"MH Zweig","year":"1993","unstructured":"Zweig MH . ROC plots display test accuracy, but are still limited by the study design. Clin Chem 1993; 39: 1345\u20131346.","journal-title":"Clin Chem"},{"key":"BF2404607_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"MH Zweig","year":"1993","unstructured":"Zweig MH, Campbell G . Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561\u2013577.","journal-title":"Clin Chem"},{"key":"BF2404607_CR22","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood.V95.7.2455","volume":"95","author":"TJ Hamblin","year":"2000","unstructured":"Hamblin TJ, Orchard JA, Gardiner A, Oscier DG, Davis Z, Stevenson FK . Immunoglobulin V genes and CD38 expression in CLL. Blood 2000; 95: 2455\u20132457.","journal-title":"Blood"},{"key":"BF2404607_CR23","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1182\/blood.V97.6.1892","volume":"97","author":"U Thunberg","year":"2001","unstructured":"Thunberg U, Johnson A, Roos G, Thorn I, Tobin G, Sallstrom J et al. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood 2001; 97: 1892\u20131894.","journal-title":"Blood"},{"key":"BF2404607_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/eji.200526355","volume":"36","author":"G Cutrona","year":"2006","unstructured":"Cutrona G, Colombo M, Matis S, Reverberi D, Dono M, Tarantino V et al. B lymphocytes in humans express ZAP-70 when activated in vivo. Eur J Immunol 2006; 36: 558\u2013569.","journal-title":"Eur J Immunol"},{"key":"BF2404607_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","volume":"363","author":"JA Orchard","year":"2004","unstructured":"Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105\u2013111.","journal-title":"Lancet"},{"key":"BF2404607_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1182\/blood-2005-04-1677","volume":"107","author":"JL Binet","year":"2006","unstructured":"Binet JL, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, Dighiero G et al. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 2006; 107: 859\u2013861.","journal-title":"Blood"},{"key":"BF2404607_CR27","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2005-02-0819","volume":"107","author":"E Montserrat","year":"2006","unstructured":"Montserrat E, Moreno C, Esteve J, Urbano-Ispizua A, Gine E, Bosch F . How I treat refractory CLL. Blood 2006; 107: 1276\u20131283.","journal-title":"Blood"},{"key":"BF2404607_CR28","first-page":"4918","volume":"58","author":"OE Bechter","year":"1998","unstructured":"Bechter OE, Eisterer W, Pall G, Hilbe W, Kuhr T, Thaler J . Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res 1998; 58: 4918\u20134922.","journal-title":"Cancer Res"},{"key":"BF2404607_CR29","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0002-9440(10)63039-8","volume":"159","author":"M Krams","year":"2001","unstructured":"Krams M, Claviez A, Heidorn K, Krupp G, Parwaresch R, Harms D et al. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Am J Pathol 2001; 159: 1925\u20131932.","journal-title":"Am J Pathol"},{"key":"BF2404607_CR30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63896-5","volume":"162","author":"M Krams","year":"2003","unstructured":"Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P . Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol 2003; 162: 1019\u20131026.","journal-title":"Am J Pathol"},{"key":"BF2404607_CR31","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1182\/blood-2004-11-4394","volume":"105","author":"P Grabowski","year":"2005","unstructured":"Grabowski P, Hultdin M, Karlsson K, Tobin G, Aleskog A, Thunberg U et al. Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status. Blood 2005; 105: 4807\u20134812.","journal-title":"Blood"},{"key":"BF2404607_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2004.06.011","volume":"340","author":"L Liu","year":"2004","unstructured":"Liu L, Lai S, Andrews LG, Tollefsbol TO . Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 2004; 340: 1\u201310.","journal-title":"Gene"},{"key":"BF2404607_CR33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nri890","volume":"2","author":"RJ Hodes","year":"2002","unstructured":"Hodes RJ, Hathcock KS, Weng NP . Telomeres in T and B cells. Nat Rev Immunol 2002; 2: 699\u2013706.","journal-title":"Nat Rev Immunol"},{"key":"BF2404607_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/PL00000708","volume":"57","author":"G Krupp","year":"2000","unstructured":"Krupp G, Klapper W, Parwaresch R . Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation. Cell Mol Life Sci 2000; 57: 464\u2013486.","journal-title":"Cell Mol Life Sci"},{"key":"BF2404607_CR35","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1038\/sj.onc.1205419","volume":"21","author":"Y Cao","year":"2002","unstructured":"Cao Y, Li H, Deb S, Liu JP . TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 2002; 21: 3130\u20133138.","journal-title":"Oncogene"},{"key":"BF2404607_CR36","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ejca.2004.12.002","volume":"41","author":"M Folini","year":"2005","unstructured":"Folini M, Brambilla C, Villa R, Gandellini P, Vignati S, Paduano F et al. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. Eur J Cancer 2005; 41: 624\u2013634.","journal-title":"Eur J Cancer"},{"key":"BF2404607_CR37","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1038\/sj.leu.2403177","volume":"17","author":"A Roth","year":"2003","unstructured":"Roth A, Vercauteren S, Sutherland HJ, Lansdorp PM . Telomerase is limiting the growth of acute myeloid leukemia cells. Leukemia 2003; 17: 2410\u20132417.","journal-title":"Leukemia"},{"key":"BF2404607_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/138920106777549768","volume":"7","author":"L Deville","year":"2006","unstructured":"Deville L, Hillion J, Lanotte M, Rousselot P, Segal-Bendirdjjan E . Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias. Curr Parm Biotechnol 2006; 7: 171\u2013183.","journal-title":"Curr Parm Biotechnol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404607","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:47:46Z","timestamp":1648781266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,8]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BF2404607"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404607","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,8]]},"assertion":[{"value":"14 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}